<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2022.1078880</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Dynamic changes in human THP-1-derived M1-to-M2 macrophage polarization during <italic>Thelazia callipaeda</italic> MIF induction</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yin</surname>
<given-names>Changzhu</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2068401"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cai</surname>
<given-names>Juan</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gou</surname>
<given-names>Yanting</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Di</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Hongri</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Lingjun</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2073064"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Luo</surname>
<given-names>Bo</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1913480"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Department of Parasitology, Zunyi Medical University</institution>, <addr-line>Zunyi</addr-line>, <country>China</country>
<uri xlink:href="https://loop.frontiersin.org/people/2068401"/>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Luis Fonte, Pedro Kouri National Institute of Tropical Medicine (IPK), Cuba</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Gissel Garcia, Hermanos Ameijeiras Hospital, Cuba; Rapeah Suppian, Universiti Sains Malaysia Health Campus, Malaysia</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Hui Liu, <email xlink:href="mailto:liuhui@zmu.edu.cn">liuhui@zmu.edu.cn</email>; Bo Luo, <email xlink:href="mailto:luobozmu@163.com">luobozmu@163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Parasite Immunology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1078880</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>12</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Yin, Cai, Gou, Li, Tang, Wang, Liu and Luo</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Yin, Cai, Gou, Li, Tang, Wang, Liu and Luo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Macrophages are innate immune cells with essential roles in the immune response during helminth infection. Particularly, the direction of macrophage polarization could contribute to pathogen trapping and killing as well as tissue repair and the resolution of type 2 inflammation. This study establishes that the recombinant protein of <italic>Thelazia callipaeda</italic> macrophage migration inhibitory factor (<italic>T.cp</italic>-MIF) induces THP-1-derived macrophages to undergo M1 to M2 type dynamic polarization, using the methods of flow cytometry, real-time quantitative PCR, differential transcriptomic analysis and western blot. Interestingly, there was an increase in protein and mRNA expression of M1-type proteins and cytokines after the use of PI3K inhibitors, suggesting that the polarization state tends to favor the M1 type after M2 type inhibition. In conclusion, the dynamic polarization mechanism of <italic>T.cp</italic>-MIF-induced human THP-1-derived macrophages from M1 to M2 type is related to the binding of TLR4. It can first affect the M1 type polarization of macrophages by activating its downstream NF-&#x3ba;B pathway. Activation of the PI3K/Akt pathway and inhibition of NF-&#x3ba;B phosphorylation affects the M2 type polarization of macrophages.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Thelazia callipaeda</italic>
</kwd>
<kwd>MIF</kwd>
<kwd>signal pathway</kwd>
<kwd>macrophage polarization</kwd>
<kwd>immune evasion mechanism</kwd>
</kwd-group>
<counts>
<fig-count count="12"/>
<table-count count="7"/>
<equation-count count="0"/>
<ref-count count="41"/>
<page-count count="14"/>
<word-count count="6019"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>1 Introduction</title>
<p>Human <italic>Thelaziasis</italic> is an arthropod-borne ocular disease, caused by <italic>Thelazia callipaeda</italic>, which is parasitic in the lacrimal ducts and conjunctival sacs and causes acute or chronic inflammation such as conjunctivitis and endophthalmitis (<xref ref-type="bibr" rid="B1">1</xref>). During chronic inflammation, the parasite&#x2019;s ability to survive and proliferate in the host for long periods is closely linked to the complex immune evasion mechanisms that result from inflammation. Much progress in understanding parasite immunity and immune evasion mechanisms has been made. However, there is a limited understanding of immunity and immune evasion mechanisms in the interaction between ocular parasites such as <italic>T. callipaeda</italic> and its hosts. In addition, this parasite has many genes that are highly homologous to those of the host, which can replicate proteins derived from worms that help the parasite evade host immunity. MIF is a regulator with multiple immune effects, which can regulate the transcription of target genes through the activation of downstream molecules by phosphorylation and participate in a series of pathophysiological processes such as cell growth and migration and inflammation and immune response regulation. There is a lot of evidence that parasite-derived MIF is similar in structure and function to human-derived MIF, affecting macrophage polarization and immune evasion (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>Macrophages, as effector cells for antigen presentation and anti-infection, can be differentiated into classically activated macrophages (M1) and alternatively activated macrophages (M2) under different stimulation conditions. In parasitic infections such as <italic>Neospora caninum</italic> and <italic>Clonorchis sinensis</italic>, macrophages show predominant M2 activation or dynamic M1 to M2 polarization. Macrophages play a crucial role in parasite immune evasion by suppressing the inflammatory response, promoting chronic infection, and facilitating long-term parasitism (<xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B6">6</xref>). Macrophage polarization is regulated by many signaling molecules and pathways. Studies have shown that a variety of TLR ligands bind to TLRs and activate signaling pathways related to macrophage polarization, producing pro-inflammatory or anti-inflammatory factors, which in turn affect macrophage polarization (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). The related signaling pathways of macrophage polarization mediated by TLRs mainly include NF-&#x3ba;B, PI3K/Akt, JAK/STAT6, p38/MAPK. Among them, NF-&#x3ba;B, p38/MAPK, and other pathways are involved in M1-type polarization (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>), while PI3K/Akt, JAK/STAT6, B7H3/STAT3, mTOR, and other pathways are involved in M2-type polarization (<xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>
<italic>T.cp</italic>-MIF inhibits THP-1 macrophage migration and induces the M2 phenotype polarization of THP-1 macrophages through TLR4 binding and PI3K-Akt pathway activation (<xref ref-type="bibr" rid="B14">14</xref>). Recombinant <italic>T.cp</italic>-MIF protein induces THP-1-derived macrophages to undergo M1 to M2 type polarization. Further, we want to know whether this change is a dynamic process. The critical time nodes of macrophage M1 to M2 transition were analyzed and the expression levels of some important molecules were verified. Based on the transcriptome data, we analyzed the related signaling pathways and found that this dynamic polarization was mediated by TLR4/NF-&#x3ba;B and TLR4/PI3K/Akt signaling pathways. This study therefore aimed to understand how parasite- derived MIF regulates and affects the process and direction of host macrophages polarization. We sought to provided some reference information to understand the immune regulatory mechanisms involved in <italic>Thelazia callipaeda&#x2019;s</italic> interaction with its hosts.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>2 Materials and methods</title>
<sec id="s2_1">
<title>2.1 Expression and purification of <italic>T.cp</italic>-MIF protein</title>
<p>The expression and purification process of <italic>T.cp</italic>-MIF was described by Cai J (<xref ref-type="bibr" rid="B14">14</xref>). Genome-wide information on <italic>T.cp</italic>-MIF was obtained from (Gene ID Cluster-6025.14069). The <italic>T.cp</italic>-MIF gene is 620 bp in length&#x2014;with an open reading frame of 345 bp, encoding 115 amino acids&#x2014;and a molecular weight of about 14.37 kDa. The <italic>T.cp</italic>-MIF gene was inserted into the prokaryotic expression vector pET-SUMO (Novagen, Madison, WI, USA) to construct a pET-SUMO-MIF plasmid, which was expressed in <italic>E.coli</italic> BL21 (DE3) with 1 mmol/L isopropyl-&#x3b2;-D-thiogalactopyranoside (IPTG), and purified by HisLink&#x2122; affinity chromatography columns at a preservation concentration of 10 mg/mL.</p>
</sec>
<sec id="s2_2">
<title>2.2 Cell culture and induction</title>
<p>Human leukemia THP-1 monocytes were purchased from the Shanghai Cell Bank of the Chinese Academy of Sciences. THP-1 cells were cultured as suspension cells in RPMI1640 medium containing 10% fetal bovine serum, 1% double antibody, and 0.05 mM sodium pyruvate in a 37 &#xb0;C, 5% CO<sub>2</sub> cell culture incubator. One percent of the dual antibodies are composed of a penicillin-streptomycin solution. THP-1 cells in logarithmic growth phase cells in good growth condition were inoculated uniformly at a density of 1&#xd7;106 cells/mL in a culture dish of 10 cm in diameter and incubated with PMA (100 ng/mL) (Sigma Corporation, USA) in the medium for 48 h to induce adherent macrophages and whether the induction was successful was determined by changes in cell morphology and surface markers. On this basis, 50 ng/mL <italic>T.cp</italic>-MIF was used for different times according to the experimental grouping.</p>
</sec>
<sec id="s2_3">
<title>2.3 Transcriptome sequencing and bioinformatic analysis</title>
<p>The induced THP-1-derived macrophages were cultured in complete medium (RPMI 1640 medium containing 10% fetal bovine serum, 1% double antibody, 0.05 mM sodium pyruvate) containing <italic>T.cp</italic>-MIF (50 ng/mL) for 24 and 48 hours, and THP-1-derived macrophages without <italic>T.cp</italic>-MIF were used as a control group. The experimental groups consisted of cells treated with <italic>T.cp</italic>-MIF for 24 and 48 hours, with 3 samples in each group. The steps of transcriptome sequencing library building included total RNA extraction, RNA quality detection and fragmentation, cDNA generation by reverse transcription, end complementation, addition A- tail, connector addition, PCR amplification, and Illumina machine sequencing. After sequencing, DESeq software was used for standardized processing. According to the criteria of difference multiple &gt;2 and difference significance&lt;0.05, differentially expressed protein-coding genes were screened for GO functional analysis and KEGG pathway enrichment.</p>
</sec>
<sec id="s2_4">
<title>2.4 Flow cytometry analysis</title>
<p>To detect the effect of <italic>T.cp</italic>-MIF recombinant protein on THP-1 macrophage polarization, THP-1 macrophages were collected and treated with fluorescein isothiocyanate (FITC)-labeled anti-human CD11b antibody, phycoerythrin (PE)-labeled anti-human CD14, phycoerythrin (PE)-labeled anti-human CD86 antibody and allophycocyanin (APC)-labeled anti-human CD206 were incubated together (Invitrogen, USA). The concentration of antibodies used in the flow cytometry analysis (of 100 5-&#xb5;L tests in total) was 0.5&#xb5;g/test. We added 50 ng/mL <italic>T.cp</italic>-MIF for induction, centrifugated the samples at 1200 rpm after 12&#xa0;h, 24&#xa0;h, 36&#xa0;h, and 48&#xa0;h, centrifuged for 10&#xa0;min, discarded the supernatant, and added 200 &#xb5;L of PBS to resuspend. The cells were incubated at 4 &#xb0;C for 30 minutes, 1.5 mL of PBS was added and centrifuged at 1200 rpm for 10 minutes; the supernatant was discarded, and 300 &#xb5;L of PBS were added to resuspend and mix the cells, which were transferred to a flow cytometer. The percentage of cells double labeled with CD11b and CD14 antibodies, which could be identified as macrophages, reached over 85%, and subsequent experiments could be carried out on this basis. If the percentage of CD11b and CD86 double positivity was above 85%, the population could be identified as M1 type macrophages, and if the percentage of CD11b and CD206 double positivity was above 85%, it could be identified as M2 type macrophages.</p>
</sec>
<sec id="s2_5">
<title>2.5 Real-time fluorescent quantitative polymerase chain reaction (RT-qPCR) analysis of the cytokine transcripts</title>
<p>Total RNA was isolated from macrophages in different groups using Trizol (Takara Corporation, Japan) and converted to cDNA. The reverse transcription system was prepared in a de-enzymatic octet tube and placed in the PCR instrument for reverse transcription. The reverse transcription system is shown in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. Then, cDNA was obtained using PrimeScriptTM RT Reagent Kit according to the manufacturer&#x2019;s instructions (Takara Corporation, Japan). Quantitative real-time PCR was conducted using a SYBR Premix Ex Taq Kit (Takara Corporation, Japan) and a quantitative fluorescence PCR instrument (Bio-Rad Corporation, USA). Fold changes in gene expression were calculated using the 2<sup>&#x2212;&#x394;&#x394;Ct</sup> method to calculate the relative mRNA expression of TNF-&#x3b1; and Arg1. The primer pairs used for these analyses are shown in <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>. The PCR reaction system and procedures are shown in <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Reverse transcription system (20 &#xb5;L).</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Component</th>
<th valign="top" align="center">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">5&#xd7; PrimeScript Buffer</td>
<td valign="top" align="center">4 &#xb5;L</td>
</tr>
<tr>
<td valign="top" align="left">PrimeScript RT Enzyme Mix I</td>
<td valign="top" align="center">1 &#xb5;L</td>
</tr>
<tr>
<td valign="top" align="left">Oligo dT Primer (50 &#xb5;M)</td>
<td valign="top" align="center">1 &#xb5;L</td>
</tr>
<tr>
<td valign="top" align="left">Random 6-mers (100 &#xb5;M)</td>
<td valign="top" align="center">1 &#xb5;L</td>
</tr>
<tr>
<td valign="top" align="left">Total RNA</td>
<td valign="top" align="center">Depending on concentration</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Real-time qPCR amplification primers.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Gene</th>
<th valign="top" align="center">Primers</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="2" align="left">TNF-&#x3b1;</td>
<td valign="top" align="left">F:TTTTGCCAAGGAGTGCTAAAGA</td>
</tr>
<tr>
<td valign="top" align="left">R:AACCCTCTGCACCCAGTTTTC</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Arg1</td>
<td valign="top" align="left">F:GTGGAAACTTGCATGGACAAC</td>
</tr>
<tr>
<td valign="top" align="left">R:AATCCTGGCACATCGGGAATC</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">GAPDH</td>
<td valign="top" align="left">F:GGAGCGAGATCCCTCCAAAAT</td>
</tr>
<tr>
<td valign="top" align="left">R:GGCTGTTGTCATACTTCTCATGG</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>RT-qPCR reaction system (25 &#xb5;L).</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Component</th>
<th valign="top" align="center">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">TB Green Premix Ex Taq II (2&#xd7;)</td>
<td valign="top" align="center">12.5 &#xb5;L</td>
</tr>
<tr>
<td valign="top" align="left">Forward Primer (10 &#xb5;M)</td>
<td valign="top" align="center">1 &#xb5;L</td>
</tr>
<tr>
<td valign="top" align="left">Reverse Primer (10 &#xb5;M)</td>
<td valign="top" align="center">1 &#xb5;L</td>
</tr>
<tr>
<td valign="top" align="left">Template (cDNA)</td>
<td valign="top" align="center">2 &#xb5;L</td>
</tr>
<tr>
<td valign="top" align="left">RNase-Free ddH2O</td>
<td valign="top" align="center">Up to 25 &#xb5;L</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_6">
<title>2.6 Western blotting</title>
<p>Cells of different groups were fully lysed on ice for 30&#xa0;min using the ready-made RNAiso Plus lysis solution, gently scraped off with a clean cell scraper, and centrifuged for 15 minutes at 13,000 rpm at 4 &#xb0;C. The supernatant was aspirated to obtain the cellular proteins, which were denatured by boiling and used for experiments. After the protein concentration was detected by the protein BCA method, the protein sample was added to the sample well to start electrophoresis. The upper layer of separated gum is 10% and the lower layer of concentrated gum is 4%. Protein samples were added to the sample wells (minimum quality assurance of 20 &#xb5;g of protein per well). The electrophoresis was started after adding the appropriate amount of electrophoresis solution in the electrophoresis tank with an initial potential difference of 80 V. When the bromophenol blue ran into the separation gel (after about 40 min), the voltage was adjusted to 100 V until the end of electrophoresis. After electrophoresis, the gel was removed, and the excess gel was cut off according to the molecular weight of the protein. The gel was then placed, as per standard procedures, along with sponge pads, filter paper, and a PVDF membrane, into the transfer tank, so that the bands on the gel could be transferred to the PVDF membrane. The appropriate amount of pre-cooled transfer solution was added, and transferring was carried out at 300 mA for 90 min. The PVDF membranes were placed on a shaker for blocking at room temperature for 2 h at 45 rpm. The 5% blocking solution is composed of 2.5 g of skimmed milk powder and 50 ml of TBST.</p>
<p>After blocking, the corresponding primary antibodies such as TLR4 (Wuhan Sanying Biotechnology Co., Ltd.), NF-&#x3ba;B (Wuhan Sanying Biotechnology Co., Ltd.), p-NF-&#x3ba;B (Cell signaling technology, USA), PI3K (Wuhan Sanying Biotechnology Co., Ltd.), p-PI3K (Abcam, UK), Akt (Wuhan Sanying Biotechnology Co. Ltd.), and &#x3b2;-actin (Hangzhou Huaan Biotechnology Co., Ltd.) was separately added to the box (antibody concentrations were diluted according to the instructions), incubated at 4&#xb0;C for over 12&#xa0;h. After incubation, the membrane was washed 3 times with TBST buffer for 10&#xa0;min each time. According to the antibody dilution ratio, the goat anti-rabbit (mouse) secondary antibody (Wuhan Sanying Biotechnology Co., Ltd.) was prepared with TBST buffer and incubated at room temperature for 1&#xa0;h. Finally, the membrane was washed 3 times with TBST buffer for 10&#xa0;min each time and photographed using ECL reagent (Shanghai Qihai Futai Biotechnology Co., Ltd.) for development. Gray value analysis was performed using IPP software. As needed, we set up the TLR4 inhibitor TAK-242 pretreatment group for 6&#xa0;h, the PI3K inhibitor LY294002 pretreatment group for 12&#xa0;h and NF-&#x3ba;B p65 inhibitor JSH-23 pretreatment group for 12&#xa0;h to observe the effect of each inhibitor on macrophage polarization.</p>
</sec>
<sec id="s2_7">
<title>2.7 Statistical analysis</title>
<p>Statistical analysis was performed using SPSS 19.0 and GraphPad Prism 9.0 software was used for plotting. Measure ment data are expressed as mean &#xb1; standard deviation (<inline-formula>
<mml:math display="inline" id="im1">
<mml:mover accent="true">
<mml:mi>x</mml:mi>
<mml:mo>&#xaf;</mml:mo>
</mml:mover> </mml:math>
</inline-formula> &#xb1; SD, n = 3) using the independent sample t-test. One-way ANOVA was used for multiple groups, and the LSD-t test was used for further pairwise comparisons. <italic>P</italic>&lt;0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>3 Results</title>
<sec id="s3_1">
<title>3.1 Effect of <italic>T.cp</italic>-MIF on phenotypic molecules and cytokines associated with the polarization of human THP-1-derived macrophages</title>
<p>THP-1 cells were round in shape, with uniform cell size and suspended growth; they were round and adherent after 48&#xa0;h of Propylene glycol monomethyl ether acetate (PMA) treatment (see <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). </p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Morphological changes of THP-1 cells treated by Propylene glycol monomethyl ether acetate (PMA). <bold>(A)</bold> The suspension culture cells are round in shape, uniform in size, and they are growing in suspension. <bold>(B)</bold> PMA-induced post-adhesive cells are round or oval in shape, and they are growing anchorage-dependent. Scale bar: 50 &#xb5;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g001.tif"/>
</fig>
<p>The results of flow cytometry showed that CD11b and CD14 double-positive cells accounted for 97.7% (see <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>), suggesting that THP-1 cells were successfully induced into macrophages, which could be used as the starting point for subsequent M1/M2 polarization for 0&#xa0;h. The phenotypic molecules of THP-1-derived macrophages, namely M0 type cells, are 8.1% double positive for CD11b and CD86 (M1 type macrophages), and 0.5% for CD11b and CD206 double-positive cells (M2 type macrophages) (see <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). THP-1-derived macrophages were induced by 50 ng/mL <italic>T.cp</italic>-MIF for 12&#xa0;h and 24&#xa0;h, and the percentages of CD11b and CD86 double-positive cells were 93.6% and 95.4%, respectively (see <xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3B, C, F</bold>
</xref>). The percentages of CD11b and CD206 double-positive cells were 94.6% and 98.3% after 36&#xa0;h and 48&#xa0;h of incubation, respectively (see <xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3D&#x2013;F</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Phenotypic molecular expression in macrophages. The double-positive rate of CD11b and CD14 changed from 0.2% in suspension cells to 97.7% in adnexal cells, and the double-positive rate was greater than 95% for human THP-1-derived macrophages. * indicated <italic>P</italic>&lt;0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g002.tif"/>
</fig>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>3 The expression of phenotype molecules in M1 and M2 macrophage at different time. <bold>(A&#x2013;E)</bold> Cell flow plots. <bold>(A)</bold> Double positive rate of CD11b, CD86, CD11b and CD206 in M0 type macrophages after PMA induction. <bold>(B)</bold> The double positive rate of CD11b and CD86 after 12 h of <italic>T.cp</italic>-MIF induction was 93.6% indicating that M0 changed to M1 type macrophages under <italic>T.cp</italic>-MIF induction. <bold>(C)</bold> The double positive rate of CD11b and CD86 was 95.4% in 24 h+<italic>T.cp</italic>-MIF group, indicating that the macrophage was still M1 type at 24 h. <bold>(D)</bold> The double positive rate of CD11b and CD206 after 36 h of <italic>T.cp</italic>-MIF induction was 94.6% indicating that M1 changed to M2 type macrophages under <italic>T.cp</italic>-MIF induction. <bold>(E)</bold> The double positive rate of CD11b and CD206 was 98.3% in 48 h+<italic>T.cp</italic>-MIF group, indicating that the macrophage was still M2 type at 48 h. <bold>(F)</bold> Results are showed as the mean of three times of independent experiments (<italic>x&#x304; </italic> &#xb1; SD, n=3) * indicated <italic>P</italic>&lt;0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g003.tif"/>
</fig>
<p>According to the gene melting curve results, the melting curves of TNF-&#x3b1;, Arg1, and GAPDH are single peaks (see <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>), which indicates the specificity of the designed primers. As shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>, the mRNA expression of TNF-&#x3b1; gradually increased after induction of <italic>T.cp</italic>-MIF on THP-1 macrophages compared with the control group, reaching a peak at 12&#xa0;h and being gradually downregulated after 36&#xa0;h of action (<italic>P</italic>&lt;0.05). Compared with the experimental group at 24&#xa0;h, the expression of Arg1 mRNA increased significantly after 36&#xa0;h of action (<italic>P</italic>&lt;0.05). There was no significant difference in the expression of TNF-&#x3b1; and Arg1 mRNA between the control groups (<italic>P</italic>&gt;0.05).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Melting curves of macrophage genes and GAPDH genes. Single peak of the curve indicates the specificity of the designed primer.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g004.tif"/>
</fig>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Effects of <italic>T.cp</italic>-MIF on TNF- &#x3b1; and Arg1 at different time. TNF- &#x3b1; and Arg-1 mRNA levels were analyzed by RT-qPCR and normalized against GADPH mRNA. <bold>(A)</bold> the expression of TNF-&#x3b1;. <bold>(B)</bold> the expression of Arg1. * indicated P&lt;0.05. Results are expressed as the mean of three times of independent experiments (<italic>x&#x304; </italic> &#xb1;SD, n=3).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g005.tif"/>
</fig>
<p>Flow cytometry and real-time fluorescence quantification results showed that macrophages were mainly M1 type at 12&#xa0;h and 24&#xa0;h after the action of <italic>T.cp</italic>-MIF on macrophages, and M2 type at 36&#xa0;h and 48&#xa0;h after induction.</p>
</sec>
<sec id="s3_2">
<title>3.2 Transcriptome sequencing analysis of human THP-1 macrophages induced by <italic>T.cp</italic>-MIF</title>
<p>By transcriptome data analysis, the 24&#xa0;h up-regulated genes in the experimental group after <italic>T.cp</italic>-MIF action mainly included <italic>TLR7</italic>, <italic>TLR4</italic>, etc.; the down-regulated genes were <italic>STPG4</italic>, <italic>MSTN</italic>, etc. The up-regulated genes in the experimental group at 48&#xa0;h mainly included <italic>SCRG1</italic>, <italic>STPG4</italic>, <italic>TLR7</italic>, etc.; the down-regulated genes included <italic>FSTL5</italic>, <italic>SULT1A4</italic>, etc. The results of the GO functional enrichment analysis of differentially expressed genes are shown in <xref ref-type="table" rid="T4">
<bold>Tables&#xa0;4</bold>
</xref>, <xref ref-type="table" rid="T5">
<bold>5</bold>
</xref>. The GO pathways enriched in the 24&#xa0;h differentially expressed genes were mainly involved in the positive regulation of inflammatory response. The GO pathway enrichment of differentially expressed genes at 48&#xa0;h included the positive regulation of the inflammatory response and the activity of transmembrane signaling receptors. The results of the KEGG pathway analysis are shown in <xref ref-type="table" rid="T6">
<bold>Tables&#xa0;6</bold>
</xref>, <xref ref-type="table" rid="T7">
<bold>7</bold>
</xref>. The 24&#xa0;h up-regulated pathways in the experimental group included TLRs, NF-&#x3ba;B, chemokines, and other signaling pathways. The main genes enriched on their pathways included <italic>TLR4</italic>, <italic>TLR5</italic>, <italic>TLR7</italic>, and <italic>TLR8</italic>. The main signaling pathways up-regulated in the experimental group at 48&#xa0;h were mTOR, PI3K-Akt, PPAR and others. Combined with the previous experimental results that the yeast two-hybrid <italic>T.cp</italic>-MIF can bind to TLR4, it is hypothesized that the signaling pathways causing macrophage polarization 24&#xa0;h and 48&#xa0;h after the action of <italic>T.cp</italic>-MIF on THP-1-derived macrophages are those shown in <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>.</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>GO term list of significantly differentially expressed genes between the experimental group at 24&#xa0;h and the control group.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Category</th>
<th valign="top" align="center">Term</th>
<th valign="top" align="center">P value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Biological Process</td>
<td valign="middle" align="left">negative regulation of T-helper 1 type immune response</td>
<td valign="top" align="center">0</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">cellular response to interferon-alpha</td>
<td valign="middle" align="center">1.43E-07</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">positive regulation of inflammatory response</td>
<td valign="middle" align="center">1.75E-06</td>
</tr>
<tr>
<td valign="top" align="left">Cellular Component</td>
<td valign="middle" align="left">proteinaceous extracellular matrix</td>
<td valign="top" align="center">1.46E-10</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">extracellular space</td>
<td valign="middle" align="center">9.50E-09</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">integral component of plasma membrane</td>
<td valign="middle" align="center">9.43E-07</td>
</tr>
<tr>
<td valign="top" align="left">Molecular Function</td>
<td valign="middle" align="left">transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding</td>
<td valign="middle" align="center">0.000148402</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">Notch binding</td>
<td valign="middle" align="center">0.001113597</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">GABA-A receptor activity</td>
<td valign="middle" align="center">0.000148402</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T5" position="float">
<label>Table&#xa0;5</label>
<caption>
<p>GO term list of significantly differentially expressed genes between the experimental group at 48&#xa0;h and 24&#xa0;h.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Category</th>
<th valign="top" align="center">ID</th>
<th valign="top" align="center">P value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Biological Process</td>
<td valign="middle" align="left">regulation of Rho protein signal transduction</td>
<td valign="middle" align="center">1.80E-05</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">positive regulation of inflammatory response</td>
<td valign="middle" align="center">2.97E-05</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">regulation of cholesterol biosynthetic process</td>
<td valign="middle" align="center">9.70E-05</td>
</tr>
<tr>
<td valign="top" align="left">Cellular Component</td>
<td valign="middle" align="left">extracellular space</td>
<td valign="middle" align="center">2.11E-05</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">receptor complex</td>
<td valign="middle" align="center">0.004609</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">integral component of plasma membrane</td>
<td valign="middle" align="center">0.007478</td>
</tr>
<tr>
<td valign="top" align="left">Molecular Function</td>
<td valign="middle" align="left">transmembrane signaling receptor activity</td>
<td valign="middle" align="center">0.004398</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">G-protein coupled receptor activity</td>
<td valign="middle" align="center">0.009686</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="middle" align="left">protein binding, bridging</td>
<td valign="middle" align="center">0.000106</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T6" position="float">
<label>Table&#xa0;6</label>
<caption>
<p>List of KEGG pathways up-regulated and down-regulated between the experimental group at 24&#xa0;h and the control group 0h.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Up-regulated signaling pathways</th>
<th valign="top" align="center">Down-regulated signaling pathways</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Toll-like receptor signaling pathway</td>
<td valign="top" align="left">MicroRNAs in cancer</td>
</tr>
<tr>
<td valign="top" align="left">Cytokine-cytokine receptor interaction</td>
<td valign="top" align="left">cAMP signaling pathway</td>
</tr>
<tr>
<td valign="top" align="left">TNF signaling pathway</td>
<td valign="top" align="left">Human papillomavirus infection</td>
</tr>
<tr>
<td valign="top" align="left">Cell adhesion molecules (CAMs)</td>
<td valign="top" align="left">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left">NF-kappa B signaling pathway</td>
<td valign="top" align="left">Gastric cancer</td>
</tr>
<tr>
<td valign="top" align="left">Rheumatoid arthritis</td>
<td valign="top" align="left">Complement and coagulation cascades</td>
</tr>
<tr>
<td valign="top" align="left">Salmonella infection</td>
<td valign="top" align="left">Glycine, serine, and threonine metabolism</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T7" position="float">
<label>Table&#xa0;7</label>
<caption>
<p>List of KEGG pathways up-regulated and down-regulated between the experimental group at 48&#xa0;h and 24&#xa0;h.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Up-regulated signaling pathways</th>
<th valign="top" align="center">Down-regulated signaling pathways</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">mTOR signaling pathway</td>
<td valign="top" align="left">Cytokine-cytokine receptor interaction</td>
</tr>
<tr>
<td valign="top" align="left">PPAR signaling pathway</td>
<td valign="top" align="left">Salmonella infection</td>
</tr>
<tr>
<td valign="top" align="left">PI3K-Akt signaling pathway</td>
<td valign="top" align="left">Cytosolic DNA-sensing pathway</td>
</tr>
<tr>
<td valign="top" align="left">AMPK signaling pathway</td>
<td valign="top" align="left">Chemokine signaling pathway</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Polarization-related signaling pathway of macrophages was activated after <italic>T.cp</italic>-MIF treatment. The macrophages binded with TLR4, and <italic>T.cp</italic>-MIF activated NF-&#x3ba;B signaling pathway 24 hours after induction. At this time, macrophages showed M1 type polarization, while PI3K/AKT/mTOR signaling pathway is activated at 48 hours, making macrophages show M2 type polarization.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g006.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>3.3 Western blot assay to detect the expression levels of TLR4, NF-&#x3ba;Bp65, PI3K, and Akt protein and protein phosphorylation</title>
<p>Based on the transcriptome sequencing results of <italic>T.cp</italic>-MIF-induced THP-1-derived macrophages for 24&#xa0;h and 48&#xa0;h, we can infer that TLR4, NF-&#x3ba;B, PI3K/Akt, and other pathways may be involved in the process of macrophage polarization. Therefore, a Western blot was performed to detect the expression level of these proteins and signaling pathways in the polarization. The results are shown in <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>. TLR4 protein expression was significantly increased in each experimental group after <italic>T.cp</italic>-MIF induction compared with the control group (<italic>P</italic>&lt;0.05), and there was no significant difference between experimental groups (<italic>P</italic>&gt;0.05). Compared with the control, the expression of p-NF-&#x3ba;Bp65 protein was significantly up-regulated at 12&#xa0;h and 24&#xa0;h after the effect of <italic>T.cp</italic>-MIF, and significantly down-regulated at 36&#xa0;h and 48&#xa0;h after induction (<italic>P</italic>&lt;0.05) (see <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). Compared with the control, the expressions of p-PI3K and p-Akt proteins were not significantly different at 12&#xa0;h and 24&#xa0;h after the effect of <italic>T.cp</italic>-MIF (<italic>P</italic>&gt;0.05); while the phosphorylation levels of PI3K and Akt proteins were significantly increased at 36&#xa0;h and 48&#xa0;h after induction (<italic>P</italic>&lt;0.05) (see <xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7C, D</bold>
</xref>). There was no statistical difference in the expression levels of TLR4, p-NF-&#x3ba;Bp65, p-PI3K, and p-Akt proteins in each control group (<italic>P</italic>&gt;0.05).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Effect of <italic>T.cp</italic>-MIF on the expression of macrophage polarization-related proteins in different time. <bold>(A&#x2013;D)</bold> The protein expression levers of TLR4, NF-&#x3ba;Bp65, PI3K and AKT were analyzed by western blot and normalized against &#x3b2;-actin expression. * indicated <italic>P</italic>&lt;0.05. Results are showed as the mean of three times of independent experiments (<italic>x&#x304; </italic>&#xb1;SD, n=3).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g007.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>3.4 Effects of TLR4 inhibitor TAK-242 on macrophage polarization and the expression levels of TLR4, NF-&#x3ba;Bp65, PI3K, and Akt protein and protein phosphorylation</title>
<p>Based on the above experimental results, to further verify the role of TLR4/NF-&#x3ba;B and PI3K/Akt pathways in <italic>T.cp</italic>-MIF-induced macrophage polarization, macrophages were pretreated with TLR4 inhibitor TAK-242 and induced with <italic>T.cp</italic> -MIF for 12&#xa0;h (M1 type) and 36&#xa0;h (M2 type). The changes in TLR4, NF-&#x3ba;Bp65, p-NF-&#x3ba;Bp65, PI3K, p-PI3K, Akt, and p-Akt protein expression levels in each group of cells were detected by Western blot. The results are shown in <xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8A, B</bold>
</xref>. Compared with the <italic>T.cp</italic>-MIF group, the <italic>T.cp</italic>-MIF+TAK-242 group at 12&#xa0;h and 36&#xa0;h showed a significantly inhibited expressions of TLR4 and p-NF-&#x3ba;Bp65 proteins (<italic>P</italic>&lt;0.05). As shown in <xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8C, D</bold>
</xref>, compared with the <italic>T.cp</italic>-MIF group, the TLR4 receptor inhibitor TAK-242 can inhibit the expression of p-PI3K and p-Akt proteins for 36&#xa0;h (<italic>P</italic>&lt;0.05); while the expressions of p-PI3K and p-Akt proteins in the <italic>T.cp</italic>-MIF+TAK-242 group for 12&#xa0;h compared with those in the <italic>T.cp</italic>-MIF group were not statistically different (<italic>P</italic>&gt;0.05). Real-time fluorescence quantitative PCR was performed to detect the expression of TNF-&#x3b1; and Arg1 mRNA in each group of cells. The results are shown in <xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9</bold>
</xref>. Compared with the control group, the expressions of TNF-&#x3b1; and Arg1 in the 12&#xa0;h and 36&#xa0;h TAK-242 groups were lower than those in the control group (<italic>P</italic>&lt;0.05). Compared with the <italic>T.cp</italic>-MIF group, the expression of TNF-&#x3b1; in the <italic>T.cp</italic>-MIF+TAK-242 group at 12&#xa0;h was significantly decreased (<italic>P</italic>&lt;0.05), and the expression of Arg1 in the <italic>T.cp</italic>-MIF+TAK-242 group at 36&#xa0;h was significantly decreased (<italic>P</italic>&lt;0.05). TNF-&#x3b1; expression was significantly decreased (<italic>P</italic>&lt;0.01) and Arg1 expression was significantly increased (<italic>P</italic>&lt;0.01) in the 36&#xa0;h <italic>T.cp</italic>-MIF+TAK-242 group compared with their values in the 12&#xa0;h <italic>T.cp</italic>-MIF+TAK-242 group.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>The effect of TAK-242 on the expression of macrophage polarization-related proteins. <bold>(A&#x2013;D)</bold> The cells were pretreated with TAK-242 (the TLR4 inhibitor) for 6 h, and the expression levels of TLR4, NF-&#x3ba;Bp65, p-NF-&#x3ba;Bp65, PI3K, p-PI3K, Akt and p-Akt were detected by western blot. * indicated <italic>P</italic>&lt;0.05. Results are showed as the mean of three times of independent experiments (<italic>x&#x304; </italic>&#xb1;SD, n=3).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g008.tif"/>
</fig>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>The effect of TAK-242 on the expression of TNF-&#x3b1; and Arg1. <bold>(A)</bold> the expression of TNF-&#x3b1;. <bold>(B)</bold> the expression of Arg1. * indicated <italic>P</italic>&lt;0.05, ** indicated <italic>P</italic>&lt;0.01. Results are showed as the mean of three times of independent experiments (<italic>x&#x304; </italic>&#xb1;SD, n=3).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g009.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>3.5 Effects of PI3K inhibitor LY294002 on macrophage polarization and the levels of NF-&#x3ba;Bp65, PI3K, and Akt protein and protein phosphorylation</title>
<p>After pretreatment with the PI3K inhibitor LY294002 with <italic>T.cp</italic>-MIF to induce cells for 12&#xa0;h and 36&#xa0;h, the expression levels of TNF-&#x3b1; and Arg1 mRNA in macrophages were detected by real-time fluorescence quantitative PCR, and Western blot was performed to detect the changes in NF-&#x3ba;Bp65, p-NF-&#x3ba;Bp65, PI3K, p-PI3K, Akt, and p-Akt protein levels. The results are shown in <xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10A&#x2013;C</bold>
</xref>. Compared with the <italic>T.cp</italic>-MIF group, the expression levels of p-PI3K, p-Akt and p-NF-&#x3ba;Bp65 in the <italic>T.cp</italic>-MIF+ LY294002 group at 12&#xa0;h were not statistically different (<italic>P</italic>&gt;0.05); the protein expression of p-PI3K and p-Akt at 36&#xa0;h was significantly down-regulated, and the p-NF-&#x3ba;Bp65 protein expression levels were significantly increased (<italic>P</italic>&lt;0.05). We used real-time fluorescence quantitative PCR to detect the expression of TNF-&#x3b1; and Arg1 mRNA in each group of cells, and the results are shown in <xref ref-type="fig" rid="f11">
<bold>Figure&#xa0;11</bold>
</xref>. Compared with the control group, the expression of TNF-&#x3b1; was significantly increased (<italic>P</italic>&lt;0.05) and that of Arg1 was significantly decreased (<italic>P</italic>&lt;0.05) in the 36&#xa0;h inhibitor group. Compared with that in the <italic>T.cp-</italic>MIF group, TNF-&#x3b1; expression was significantly increased (<italic>P</italic>&lt;0.05) and Arg1 expression was significantly decreased (<italic>P</italic>&lt;0.01) in the 36&#xa0;h <italic>T.cp</italic>-MIF+LY294002 group. Compared with the 12&#xa0;h <italic>T.cp</italic>-MIF+ LY294002 group, the 36&#xa0;h <italic>T.cp-</italic>MIF+ LY294002 group showed a significant decrease in TNF-&#x3b1; (<italic>P</italic>&lt;0.01) and a significant increase in Arg1 expression (<italic>P</italic>&lt;0.05).</p>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>The effect of LY294002 on the expression of macrophage polarization-related proteins. <bold>(A&#x2013;C)</bold> The cells were pretreated with LY294002 (the PI3K inhibitor) for 12 h, and the expression levels of PI3K, p-PI3K, Akt, p-Akt, NF-&#x3ba;Bp65 and p-NF-&#x3ba;Bp65 were detected by western blot. * indicated <italic>P</italic>&lt;0.05. Results are showed as the mean of three times of independent experiments (<italic>x&#x304; </italic>&#xb1;SD, n=3).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g010.tif"/>
</fig>
<fig id="f11" position="float">
<label>Figure&#xa0;11</label>
<caption>
<p>The effect of LY294002 on the expression of TNF-&#x3b1; and Arg1. <bold>(A)</bold> the expression of TNF-&#x3b1;. <bold>(B)</bold> the expression of Arg1. * indicated <italic>P</italic>&lt;0.05, ** indicated <italic>P</italic>&lt;0.01. Results are showed as the mean of three times of independent experiments (<italic>x&#x304; </italic>&#xb1;SD, n=3).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g011.tif"/>
</fig>
</sec>
<sec id="s3_6">
<title>3.6 Effects of the NF-&#x3ba;Bp65 inhibitor JSH-23 on macrophage polarization and NF-&#x3ba;Bp65 expression levels</title>
<p>After pretreatment with the NF-&#x3ba;Bp65 inhibitor JSH-23 with <italic>T.cp</italic>-MIF to induce cells for 12&#xa0;h, a Western blot was performed to detect changes in NF-&#x3ba;Bp65 and p-NF-&#x3ba;Bp65 protein levels. The results are shown in <xref ref-type="fig" rid="f12">
<bold>Figure&#xa0;12</bold>
</xref>. Compared with the control group, the expression levels of p-NF-&#x3ba;Bp65 in <italic>T.cp</italic>-MIF group were significantly increased (<italic>P</italic>&lt;0.05). Compared with the <italic>T.cp</italic>-MIF group, the expression levels of p-NF-&#x3ba;Bp65 in the <italic>T.cp</italic>-MIF+ JSH-23 group at 12&#xa0;h were significantly down-regulated (<italic>P</italic>&lt;0.05); the protein expression levels of p-NF-&#x3ba;Bp65 in <italic>T.cp</italic>-MIF+ JSH-23 group at 36&#xa0;h were significantly down-regulated (<italic>P</italic>&lt;0.05).</p>
<fig id="f12" position="float">
<label>Figure&#xa0;12</label>
<caption>
<p>The effect of JSH-23 on the expression of macrophage polarization-related proteins. The cells were pretreated with JSH-23 (the NF-&#x3ba;B inhibitor) for 12 h, and the expression levels of NF-&#x3ba;Bp65 and p-NF-&#x3ba;Bp65 were detected by western blot. * indicated <italic>P</italic>&lt;0.05. Results are showed as the mean of three times of independent experiments (<italic>x&#x304; </italic>&#xb1;SD, n=3).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-1078880-g012.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>4 Discussion</title>
<p>
<italic>Thelazia callipaeda</italic>, as ocular parasites, can secrete a parasite-derived MIF (<italic>T.cp</italic>-MIF) that is highly similar to human-derived MIF in structure and function and can act on macrophages to cause M1/M2 type polarization, whose role in the immune interaction mechanism between conjunctival sucking nematodes and hosts is of interest. When many parasites are infected, macrophages will show the dominant activation of the M2 type or show the dynamic polarization of the M1 to the M2 type, which plays an important role in parasite immune evasion by suppressing the inflammatory response, promoting chronic infection, and favoring long-term parasitism (<xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>). THP-1 cells are widely used in the study of monocyte and macrophage-related mechanisms and signaling pathways. They have more morphological and functional characteristics similar to human primary monocytes (including cell differentiation markers), relative to human peripheral blood mononuclear cells (PBMC). They are also more easily cultured and expanded in the laboratory and have a more stable genetic background, without the problem of the individual variability of PBMC (<xref ref-type="bibr" rid="B18">18</xref>). In the present study, we detected the phenotypic molecules CD11b, CD86, and CD206, as well as the mRNA expression levels of TNF-&#x3b1; and Arg1. We confirmed that 12&#xa0;h after the induction of worm-derived <italic>T.cp</italic>-MIF, macrophages began to exhibit M1-type polarization (93.6% of CD11b and CD86 double-positive cells and a significant increase in mRNA expression of TNF-&#x3b1;). Additionally, 36&#xa0;h after the induction of worm-derived <italic>T.cp</italic>-MIF, macrophages started to show M2-type polarization (94.6% of CD11b and CD206 double-positive cells and a significant increase in the mRNA expression of Arg1). This process manifests itself as a dynamic polarization from M1 to M2 type.</p>
<p>It is known that macrophage polarization is a complex process with multifactorial interactions and is regulated by multiple intracellular and extracellular signaling molecules (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Studies have shown that a variety of TLR ligands bind to TLRs, activate TLRs and other related macrophage polarization signaling pathways, and produce pro-inflammatory or anti-inflammatory factors, which in turn affects macrophage polarization. In this study, it was found that the expression of TLR4 protein was significantly increased in each experimental group after the action of <italic>T.cp</italic>-MIF on THP-1-derived macrophages. The expression of TLR4, p-NF-&#x3ba;Bp65, p-PI3K, and p-Akt proteins was significantly decreased when THP-1-derived macrophages were treated with TLR4 inhibitor (<italic>P</italic>&lt;0.05), which verified the correlation between TLR4 and its downstream NF-&#x3ba;Bp65, PI3K, and Akt proteins. By further comparing the protein expression and cytokine expression in the TAK-242 and TAK-242+<italic>T.cp</italic>-MIF groups, it can be preliminarily confirmed that the mechanism of dynamic polarization caused by <italic>T.cp</italic>-MIF acting on THP-1-derived macrophages may be the binding to TLR4 and then activating the downstream macrophage M1/M2 type polarization-related pathway.</p>
<p>The polarization of macrophages is not only affected by signaling molecules and chemokines, but also tightly and precisely regulated by receptor stimulation or signaling cascades triggered by intracellular regulatory proteins. The main pathways affecting macrophage polarization include NF-&#x3ba;B, JAK/STAT, PI3K/Akt, and mTOR (<xref ref-type="bibr" rid="B21">21</xref>&#x2013;<xref ref-type="bibr" rid="B25">25</xref>). TLRs can regulate the expression of inflammatory factors such as IL-12 and TNF-&#x3b1; by activating NF-&#x3ba;B and AP-1 transcriptional regulators. At the same time, TLRs, as transmembrane proteins, can affect macrophage polarization by mediating JNK and PI3K/Akt pathways (<xref ref-type="bibr" rid="B26">26</xref>). Activation of the PI3K/Akt pathway has inhibitory effects on TLR-mediated macrophage inflammatory responses, while the PI3K signaling pathway can inhibit M1-type polarization and promote M2 type polarization by inhibiting the NF-&#x3ba;B pathway (<xref ref-type="bibr" rid="B27">27</xref>). Based on the experimental results, it is hypothesized that <italic>T.cp</italic>-MIF induced the M1 type polarization of macrophages through the TLR4/NF-&#x3ba;B pathway after 12&#xa0;h of action by binding to TLR4. After 36&#xa0;h, it activates the PI3K/Akt pathway, inhibits the phosphorylation of NF-&#x3ba;B protein, and induces M2 type polarization.</p>
<p>According to the differential transcriptomic expression analysis, the expression of TLR7 was also significantly increased. As one of the members of the TLRs family, its binding to ligands induced the expression of IFN-&#x3b3; and IL-6 by activating the transcription and translation-related proteins NF-&#x3ba;B and MAPK-ERK1/2 through a MyD88-dependent pathway (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). It was found that TLR7 is also involved in the dynamic polarization process of macrophages (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Therefore, the results of this study suggest the need for further understanding of the role of TLR7 in immunity to <italic>Thelazia callipaeda</italic> infection, particularly in macrophage polarization.</p>
<p>The phenotype and function of macrophages are heterogeneous and plastic, and under different stimuli, macrophages can polarize into functionally distinct M1 and M2 types, which play different roles in the host (<xref ref-type="bibr" rid="B32">32</xref>). Among the M2 type macrophage polarization, four subtypes are classified according to receptor expression and function: M2a, M2b, M2c, and M2d (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). The M2a type macrophages can be induced by IL-4 and IL-13, specifically express CD206 and CD301, and exert anti-inflammatory activity and tissue remodeling effects (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). The M2b type is induced by IL-1, LPS, and immune complexes (<xref ref-type="bibr" rid="B37">37</xref>), which express CD64, TNF-&#x3b1;, and other cytokines (<xref ref-type="bibr" rid="B38">38</xref>) to regulate the immune response. The M2c type is induced by IL-10 and glucocorticoids and expressesd TGF-&#x3b2; and IL-10, involved in tissue damage repair and matrix reconstruction (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). The M2d macrophages are induced by TLR agonists through adenosine receptors and highly express IL-10, which can induce angiogenesis and promote tumor cell growth (<xref ref-type="bibr" rid="B41">41</xref>). However, it needs to be further clarified which subtype of M2 type polarization is induced by parasite-derived <italic>T.cp</italic>-MIF, and how it plays the role of immune regulation and immune evasion in <italic>T. callipaeda</italic> infection also deserves further investigation.</p>
<p>In the present study, the molecular mechanism of <italic>T.cp</italic>-MIF-induced polarization of human macrophages was only investigated by TLR4, NF-&#x3ba;B, PI3K, and Akt pathways based on transcriptome screening data. However, the signaling pathways of macrophage polarization are intricate and complex, and the signaling between TLR4/NF-&#x3ba;B and PI3K/Akt pathways have not been elucidated. In addition, the roles and network regulatory relationships of TLR7 and other highly differentially expressed genes in macrophage polarization-related signaling pathways also deserve further study. Therefore, more in-depth studies based on transcriptome data are needed to further investigate parasit-derived <italic>T.cp</italic>-MIF-induced macrophage polarization and the mutual regulatory relationships between the pathways, as well as to gain insight into how insect-derived <italic>T.cp</italic>-MIF regulates <italic>T. callipaeda</italic> interactions with the host.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>5 Conclusions</title>
<p>The mechanism of <italic>T.cp</italic>-MIF-induced dynamic polarization of human THP-1-derived macrophages from the M1 to M2 type is related to TLR4 binding. It can affect M1 macrophage type polarization by activating its downstream NF-&#x3ba;B pathway first, further activating the PI3K/Akt pathway, and inhibiting NF-&#x3ba;B phosphorylation to promote M2 type macrophage polarization.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: PRJNA902947 (BioProject).</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>All authors listed have made a substantial, direct, and intellectual contribution to the work, and approved it for publication.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This study was supported by grants from the National Natural Science Foundation of China (No. 82060374) and the Science and Technology Foundation of Guizhou Province (Nos. QKE-JC (2020)1Y348, QKH-PTRC (2017)5733-027) and QKH-PTRC (2020)-004).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We would like to thank BL and HL for them assistance in English grammar and spelling corrections.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>APC, Allophycocyanin; Arg1, arginase 1; FBS, fetal bovine serum; FITC, fluorescein isothiocyanate; MIF, macrophage migration inhibitory factor; NCBI, National Center for Biotechnology Information; NF-&#x3ba;B, Nuclear factor kappa-B; PE, Phycoerythrin; PI3K, Phosphatidylinositol 3-kinase; PMA, Propylene glycol monomethyl ether acetate; RT-qPCR, Real-time fluorescent quantitative PCR; RPMI, Roswell Park Memorial Institute; SDS, sodium dodecyl sulfate; <italic>T. callipaeda</italic>, <italic>Thelazia callipaeda</italic>; <italic>T.cp</italic>-MIF, <italic>Thelazia callipaeda</italic>-macrophage migration inhibitory factor; THP-1, human monocyte leukemia cell line; TLR4, toll-like receptor 4; TNF-&#x3b1;, tumor necrosis factor-&#x3b1;.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarff</surname> <given-names>A</given-names>
</name>
<name>
<surname>Behrens</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Ocular Emergencies: Red Eye</article-title>. <source>Med Clin North Am</source> (<year>2017</year>) <volume>101</volume>(<issue>3</issue>):<page-range>615&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mcna.2016.12.013</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ehsan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Song</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Characterization of a secreted macrophage migration inhibitory factor homologue of the parasitic nematode Haemonchus Contortus acting at the parasite-host cell interface</article-title>. <source>Oncotarget</source> (<year>2017</year>) <volume>8</volume>(<issue>25</issue>):<page-range>40052&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/oncotarget.16675</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sundaravadivel</surname> <given-names>P</given-names>
</name>
<name>
<surname>Tripathi</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Jha</surname> <given-names>RK</given-names>
</name>
<name>
<surname>Badrukhiya</surname> <given-names>J</given-names>
</name>
<name>
<surname>Basak</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Variations in macrophage migration inhibitory factor gene are not associated with visceral leishmaniasis in India</article-title>. <source>J Infect Public Health</source> (<year>2019</year>) <volume>12</volume>(<issue>3</issue>):<page-range>380&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jiph.2018.12.011</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Adapala</surname> <given-names>N</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Peroxisome Proliferator-Activated Receptor-&#x3b3;-Mediated Polarization of Macrophages in Leishmania Infection</article-title>. <source>PPAR Res</source> (<year>2012</year>) <volume>1)</volume>:<page-range>796235&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2012/796235</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Chi</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Parasitic antigens alter macrophage polarization during Schistosoma japonicum infection in mice</article-title>. <source>Parasites Vectors</source> (<year>2014</year>) <volume>7</volume>(<issue>1</issue>):<elocation-id>122</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1756-3305-7-122</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Kwak</surname> <given-names>YS</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Sohn</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Yong</surname> <given-names>TS</given-names>
</name>
<etal/>
</person-group>. <article-title>Clonorchis sinensis antigens alter hepatic macrophage polarization <italic>in vitro</italic> and in vivo</article-title>. <source>PloS Negl Trop Dis</source> (<year>2017</year>) <volume>11</volume>(<issue>5</issue>):<elocation-id>e0005614</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0005614</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>H</given-names>
</name>
<name>
<surname>Han</surname> <given-names>X</given-names>
</name>
<name>
<surname>Weng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth</article-title>. <source>J Immunother Cancer</source> (<year>2019</year>) <volume>7</volume>(<issue>1</issue>):<fpage>326</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40425-019-0817-4</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Hirudin Protects Against Kidney Damage in Streptozotocin-Induced Diabetic Nephropathy Rats by Inhibiting Inflammation <italic>via</italic> P38 MAPK/NF-&#x3ba;B Pathway[J]</article-title>. <source>Drug Design Dev Ther</source> (<year>2020</year>) <volume>14</volume>:<page-range>3223&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/DDDT.S257613</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>FC</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>SH</given-names>
</name>
<etal/>
</person-group>. <article-title>Interleukin 26 Skews Macrophage Polarization Towards M1 Phenotype by Activating cJUN and the NF-&#x3ba;B Pathway</article-title>. <source>Cells</source> (<year>2020</year>) <volume>9</volume>(<issue>4</issue>):<elocation-id>938</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells9040938</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deramaudt</surname> <given-names>TB</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vinit</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bonay</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Sulforaphane reduces intracellular survival of Staphylococcus aureus in macrophages through inhibition of JNK and p38 MAPK-induced inflammation</article-title>. <source>Int J Mol Med</source> (<year>2020</year>) <volume>45</volume>(<issue>6</issue>):<page-range>1927&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/ijmm.2020.4563</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>X</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Cancer cell-expressed B7-H3 regulates the differentiation of tumor-associated macrophages in human colorectal carcinoma</article-title>. <source>Oncol Lett</source> (<year>2017</year>) <volume>14</volume>(<issue>5</issue>):<page-range>6177&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/ol.2017.6935</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer</article-title>. <source>J Hematol Oncol</source> (<year>2020</year>) <volume>13</volume>(<issue>1</issue>):<fpage>156</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13045-020-00991-2</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jim&#xe9;nez-Garc&#xed;a</surname> <given-names>L</given-names>
</name>
<name>
<surname>Higueras</surname> <given-names>M&#xc1;</given-names>
</name>
<name>
<surname>Herranz</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez-L&#xf3;pez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Luque</surname> <given-names>A</given-names>
</name>
<name>
<surname>de Las Heras</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>A hispanolone-derived diterpenoid inhibits M2-Macrophage polarization <italic>in vitro via</italic> JAK/STAT and attenuates chitin induced inflammation in vivo</article-title>. <source>Biochem Pharmacol</source> (<year>2018</year>) <volume>154</volume>:<page-range>373&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bcp.2018.06.002</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname> <given-names>J</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage migration inhibitory factor of Thelazia callipaeda induces M2-like macrophage polarization through TLR4-mediated activation of the PI3K-Akt pathway[J]</article-title>. <source>FASEB J</source> (<year>2021</year>) <volume>35</volume>(<issue>9</issue>):<elocation-id>e21866</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.202100676R</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Chi</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Parasitic antigens alter macrophage polarization during Schistosoma japonicum infection in mice</article-title>. <source>Parasites Vectors</source> (<year>2014</year>) <volume>7</volume>(<issue>1</issue>):<elocation-id>122</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1756-3305-7-122</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>X</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>P</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Peroxisome proliferator-activated receptor-&#x3b3;-mediated polarization of macrophages in <italic>Neospora caninum</italic> infection</article-title>. <source>Exp Parasitol</source> (<year>2017</year>) <volume>178</volume>:<fpage>37</fpage>&#x2013;<lpage>44</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.exppara.2017.05.002</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chanput</surname> <given-names>W</given-names>
</name>
<name>
<surname>Mes</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Wichers</surname> <given-names>HJ</given-names>
</name>
</person-group>. <article-title>THP-1 cell line: an <italic>in vitro</italic> cell model for immune modulation approach[J]</article-title>. <source>Int Immunopharmacol</source> (<year>2014</year>) <volume>23</volume>(<issue>1</issue>):<fpage>37</fpage>&#x2013;<lpage>45</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2014.08.002</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Kwak</surname> <given-names>YS</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Sohn</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Yong</surname> <given-names>TS</given-names>
</name>
<etal/>
</person-group>. <article-title>
<italic>Clonorchis sinensis</italic> antigens alter hepatic macrophage polarization <italic>in vitro</italic> and in vivo</article-title>. <source>PloS Negl Trop Dis</source> (<year>2017</year>) <volume>11</volume>(<issue>5</issue>):<elocation-id>e0005614</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0005614</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wen</surname> <given-names>ZF</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1</article-title>. <source>J Immunother Cancer</source> (<year>2018</year>) <volume>6</volume>(<issue>1</issue>):<fpage>151</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40425-018-0452-5</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>H</given-names>
</name>
<name>
<surname>Na</surname> <given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>The biological function and significance of CD74 in immune diseases</article-title>. <source>Inflammation Res</source> (<year>2017</year>) <volume>66</volume>(<issue>3</issue>):<page-range>209&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00011-016-0995-1</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Du</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw</article-title>. <source>FASEB J</source> (<year>2019</year>) <volume>33</volume>(<issue>4</issue>):<page-range>5208&#x2013;19</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.201801791RR</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis</article-title>. <source>Front Med (Lausanne)</source> (<year>2020</year>) <volume>7</volume>:<elocation-id>71</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmed.2020.00071</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Um</surname> <given-names>HN</given-names>
</name>
<name>
<surname>Jang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>YA</given-names>
</name>
<name>
<surname>Park</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Eosinophil Activation by Toll-Like Receptor 4 Ligands Regulates Macrophage Polarization</article-title>. <source>Front Cell Dev Biol</source> (<year>2019</year>) <volume>7</volume>:<elocation-id>329</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2019.00329</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yunna</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mengru</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>W</given-names>
</name>
<name>
<surname>Weidong</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Macrophage M1/M2 polarization</article-title>. <source>Eur J Pharmacol</source> (<year>2020</year>) <volume>877</volume>:<elocation-id>173090</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2020.173090</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Adler</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Vella</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage polarization and meta-inflammation</article-title>. <source>Transl Res</source> (<year>2018</year>) <volume>191</volume>:<fpage>29</fpage>&#x2013;<lpage>44</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.trsl.2017.10.004</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xi</surname> <given-names>ZD</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Xi</surname> <given-names>YB</given-names>
</name>
</person-group>. <article-title>Macrophage migration inhibitory factor enhances lipopolysaccharide-induced fibroblast proliferation by inducing toll-like receptor 4</article-title>. <source>BMC Musculoskelet Disord</source> (<year>2016</year>) <volume>17</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>5</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12891-016-0895-0</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishikoba</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kumagai</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kanmura</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ono</surname> <given-names>M</given-names>
</name>
<name>
<surname>Eguchi</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>HGF-MET Signaling Shifts M1 Macrophages Toward an M2-Like Phenotype Through PI3K-Mediated Induction of Arginase-1 Expression</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>2135</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.02135</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishikoba</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kumagai</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kanmura</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ono</surname> <given-names>M</given-names>
</name>
<name>
<surname>Eguchi</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>R848 Is Involved in the Antibacterial Immune Response of Golden Pompano (Trachinotus ovatus) Through TLR7/8-MyD88-NF-&#x3ba;B-Signaling Pathway</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>11</volume>:<elocation-id>617522</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.617522</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>FKBP5 Regulates RIG-I-Mediated NF-&#x3ba;B Activation and Influenza a Virus Infection</article-title>. <source>Viruses</source> (<year>2020</year>) <volume>12</volume>(<issue>6</issue>):<elocation-id>672</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/v12060672</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato-Kaneko</surname> <given-names>F</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ahmadi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Hosoya</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kaneda</surname> <given-names>MM</given-names>
</name>
<etal/>
</person-group>. <article-title>Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer</article-title>. <source>JCI Insight</source> (<year>2017</year>) <volume>2</volume>(<issue>18</issue>):<elocation-id>e93397</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/jci.insight.93397</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celhar</surname> <given-names>T</given-names>
</name>
<name>
<surname>Pereira-Lopes</surname> <given-names>S</given-names>
</name>
<name>
<surname>Thornhill</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Dhillon</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Poidinger</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <source>31 Int Immunol</source> (<year>2016</year>) <volume>28</volume>(<issue>5</issue>):<page-range>223&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/intimm/dxv066</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Stokes</surname> <given-names>JV</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>W</given-names>
</name>
<name>
<surname>Pruett</surname> <given-names>SB</given-names>
</name>
</person-group>. <article-title>An optimized flow cytometry panel for classifying macrophage polarization</article-title>. <source>J Immunol Methods</source> (<year>2022</year>) <volume>511</volume>:<elocation-id>113378</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jim.2022.113378</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chistiakov</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Bobryshev</surname> <given-names>YV</given-names>
</name>
<name>
<surname>Nikiforov</surname> <given-names>NG</given-names>
</name>
<name>
<surname>Elizova</surname> <given-names>NV</given-names>
</name>
<name>
<surname>Sobenin</surname> <given-names>IA</given-names>
</name>
<name>
<surname>Orekhov</surname> <given-names>AN</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes</article-title>. <source>Int J Cardiol</source> (<year>2015</year>) <volume>184</volume>:<page-range>436&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijcard.2015.03.055</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zen</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Molecular mechanisms that influence the macrophage M1-M2 polarization balance</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>28</volume>:<elocation-id>614</elocation-id>(<issue>5</issue>). doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2014.00614</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shapouri-Moghaddam</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mohammadian</surname> <given-names>S</given-names>
</name>
<name>
<surname>Vazini</surname> <given-names>H</given-names>
</name>
<name>
<surname>Taghadosi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Esmaeili</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Mardani</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage plasticity, polarization, and function in health and disease</article-title>. <source>J Cell Physiol</source> (<year>2018</year>) <volume>233</volume>(<issue>9</issue>):<page-range>6425&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcp.26429</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ahati</surname> <given-names>P</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>M2a Macrophage-Secreted CHI3L1 Promotes Extracellular Matrix Metabolic Imbalances via Activation of IL-13R&#x3b1;2/MAPK Pathway in Rat Intervertebral Disc Degeneration</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>666361</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.666361</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsieh</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>YP</given-names>
</name>
<name>
<surname>Hung</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>YH</given-names>
</name>
</person-group>. <article-title>M2b macrophage subset decrement as an indicator of cognitive function in Alzheimer's disease</article-title>. <source>Psychiatry Clin Neurosci</source> (<year>2020</year>) <volume>74</volume>(<issue>7</issue>):<page-range>383&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/pcn.13000</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohama</surname> <given-names>H</given-names>
</name>
<name>
<surname>Asai</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ito</surname> <given-names>I</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kobayashi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Higuchi</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>M2b Macrophage Elimination and Improved Resistance of Mice with Chronic Alcohol Consumption to Opportunistic Infections</article-title>. <source>Am J Pathol</source> (<year>2015</year>) <volume>185</volume>(<issue>2</issue>):<page-range>420&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajpath.2014.09.022</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carta</surname> <given-names>T</given-names>
</name>
<name>
<surname>Razzuoli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Fruscione</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zinellu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Meloni</surname> <given-names>D</given-names>
</name>
<name>
<surname>Anfossi</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparative Phenotypic and Functional Analyses of the Effects of IL-10 or TGF-&#x3b2; on Porcine Macrophages</article-title>. <source>Anim (Basel)</source> (<year>2021</year>) <volume>11</volume>(<issue>4</issue>):<elocation-id>1098</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ani11041098</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hobby</surname> <given-names>ARH</given-names>
</name>
<name>
<surname>Berretta</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Eaton</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Kubo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Feldsott</surname> <given-names>E</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Cortical bone stem cells modify cardiac inflammation after myocardial infarction by inducing a novel macrophage phenotype</article-title>. <source>Am J Physiol Heart Circ Physiol</source> (<year>2021</year>) <volume>321</volume>(<issue>4</issue>):<page-range>H684&#x2013;701</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpheart.00304.2021</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Peters</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Nieman</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>M</given-names>
</name>
<name>
<surname>Watson</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro</article-title>. <source>Br J Cancer</source> (<year>2015</year>) <volume>13</volume>(<issue>5</issue>):<page-range>738&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/bjc.2015.292</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>